Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
James F Parslow is Interim CEO and CFO at Xenetic Biosciences. OQRO lists 1 transaction filed with the SEC under this name, the latest on Apr 23, 2026, each linked to the official Form 4.
Interim CEO and CFO
Disclosures on record
1
Companies involved
1
As of the latest filing on , James F Parslow reported holding 100,000 shares of Xenetic Biosciences (XBIO), worth about $149K at the last close of $1 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Xenetic Biosciences XBIO | 100,000 | 100K direct | $1 | $149K | Apr 21, 2026 |
Is this James F Parslow’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Apr 21, 2026100Kdisclosed Apr 23
DetailsOfficial recordOn the latest SEC Form 4, dated Apr 21, 2026, James F Parslow reported holding 100,000 shares of Xenetic Biosciences (XBIO). At the last close of $1 on Nov 16, 2026, that is about $149K. This is the stake disclosed in filings, not a net worth.